CPA
NVRO

Capital Performance Advisors’s NEVRO CORP. NVRO Stock Holding History

Capital Performance Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-33
Closed -$184 – 2844
2024
Q3 		$184 Buy
+33
New +$231 ﹤0.01% 2575

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Capital Performance Advisors's NVRO Position: Q4 2024 in Review

Capital Performance Advisors sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 33 shares — an estimated $184 sold.

Capital Performance Advisors first reported a position in NVRO in Q3 2024 and held it in 1 quarter. The position peaked at $184 in Q3 2024. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.

  • Capital Performance Advisors reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 33 NEVRO CORP. shares in Q4 2024, an estimated $184.
  • Capital Performance Advisors first reported a position in NEVRO CORP. in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's NEVRO CORP. position peaked at $184 in Q3 2024.
  • 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.